Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of vaginal prebiotic gel plus oral metronidazole on treatment and recurrence of bacterial vaginosis
IRCT2015121721917N5Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of metronidazole in bacterial vaginosis (BV) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Clinical cure of bacterial vaginosis and Recurrence of bacterial vaginosis. Started Feb 2016; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on IRCT2015121721917N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015121721917N5.